Acelrx Pharmaceuticals Inc Propiedad institucional
¿Qué es el Propiedad institucional de Acelrx Pharmaceuticals Inc?
El Propiedad institucional de Acelrx Pharmaceuticals Inc es 11.78%
¿Cuál es la definición de Propiedad institucional ?
La propiedad institucional es la cantidad de acciones disponibles de una compañía que son propiedad de fondos mutuos o de pensiones, compañías de seguros, empresas de inversión, dotaciones u otras entidades grandes que administran fondos en nombre de otros.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Propiedad institucional de compañías en Sector Health Care en NASDAQ en comparadas con Acelrx Pharmaceuticals Inc
¿Qué hace Acelrx Pharmaceuticals Inc?
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Empresas con propiedad institucional similar a Acelrx Pharmaceuticals Inc
- The Bitcoin Fund tiene Propiedad institucional de 11.76%
- Lakestar Spac I Se Eo 1 tiene Propiedad institucional de 11.76%
- Rupert Resources tiene Propiedad institucional de 11.76%
- Perspective Therapeutics Inc tiene Propiedad institucional de 11.77%
- Johnson Controls-Hitachi Air Conditioning India tiene Propiedad institucional de 11.77%
- Mesa Royalty Trust tiene Propiedad institucional de 11.77%
- Acelrx Pharmaceuticals Inc tiene Propiedad institucional de 11.78%
- CITIC Resources tiene Propiedad institucional de 11.79%
- Pro Medicus tiene Propiedad institucional de 11.80%
- Chesapeake Gold tiene Propiedad institucional de 11.81%
- Accent tiene Propiedad institucional de 11.81%
- Latitude Ltd tiene Propiedad institucional de 11.81%
- DelphX Capital Markets tiene Propiedad institucional de 11.81%